IsoDent Oy is an innovative oral-care product manufacturer from Arctic Finland. Our current top priority is to manufacture very effective mouthwash-serie against parodontitis, periodontitis and peri-implantitis, based on the patented Lipoxin A4-ME (NCD-1001). This material is working as a transfer agent for inflammation resolution (tissue modulation therapy). There is no actimicrobic ingredient included in the formula. The product development is done together with Nocendra Inc from USA. The foundative research work is performed also in USA by Prof Vandyke and Dr Serhan. When using this mouthwash body`s own immunological response is curing these serious diseases. This is why we are expecting that this revolutionary methodology is replacing traditional Chlorhexidine technics in coming years.